Translational Research in Oncology (TRIO) Enrolls First Patient in Early Breast Cancer Phase 2 Trial
September 15, 2020 09:00 ET
|
Translational Research in Oncology
EDMONTON, Alberta, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of the first patient in a...
Translational Research in Oncology (TRIO) Appoints Industry and Clinical Experts to Board of Directors
February 03, 2020 10:00 ET
|
Translational Research in Oncology
EDMONTON, Alberta, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced the appointment of two new members...
Translational Research in Oncology (TRIO) Initiates Phase I Study for MT-5111
November 14, 2019 08:00 ET
|
Translational Research in Oncology
EDMONTON, Alberta, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced enrolment of the first patient in a...
Translational Research in Oncology (TRIO) Partners With Molecular Templates for First-In-Human Phase I Study for MT-5111
April 25, 2019 10:06 ET
|
Translational Research in Oncology
EDMONTON, Alberta, April 25, 2019 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced it has partnered with Molecular...
Исследовательский центр TRIO включает первого пациента в клиническое исследование III фазы по программе борьбы с раком молочной железы NATALEE
January 16, 2019 01:21 ET
|
Translational Research in Oncology
Эдмонтон, Альберта, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) в сотрудничестве с Novartis и под руководством доктора медицинских наук, председателя правления и...
TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial
January 14, 2019 10:15 ET
|
Translational Research in Oncology
EDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon, MD, PhD, TRIO...
TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History
July 09, 2018 16:16 ET
|
Translational Research in Oncology
EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced a collaboration with Novartis on its upcoming phase III clinical trial of ribociclib...
TRIO Announces Participation in the Avoca Diligent™ Prequalification Platform
January 24, 2018 07:00 ET
|
Translational Research in Oncology
EDMONTON, Alberta, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO) is pleased to announce its participation in the Avoca Diligent™ Prequalification Platform. The purpose...